• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Endocrine . Association of blood glucose level and prognosis of inpatients with coexistent diabetes and COVID-19

tetano

Editor, Senior Moderator
Endocrine


. 2021 Oct 30.
doi: 10.1007/s12020-021-02923-7. Online ahead of print.
Association of blood glucose level and prognosis of inpatients with coexistent diabetes and COVID-19


Weiwei Duan[SUP] #[/SUP][SUP] 1 2 3 4 [/SUP], Liangyu Li[SUP] #[/SUP][SUP] 5 6 [/SUP], Xuesong Li[SUP] #[/SUP][SUP] 7 [/SUP], Mengyan Zhu[SUP] #[/SUP][SUP] 5 6 [/SUP], Lingxiang Wu[SUP] 5 6 [/SUP], Wei Wu[SUP] 5 6 [/SUP], Kening Li[SUP] 5 6 [/SUP], Yuan Liang[SUP] 5 6 [/SUP], Rong Ding[SUP] 5 6 [/SUP], Wenhua You[SUP] 5 6 [/SUP], Ziyu Wang[SUP] 5 6 [/SUP], Bin Huang[SUP] 5 6 [/SUP], Min Wu[SUP] 5 6 [/SUP], Tingting Zhang[SUP] 5 6 [/SUP], Jie Li[SUP] 5 6 [/SUP], Yan Li[SUP] 5 6 [/SUP], Jiaofang Shao[SUP] 5 6 [/SUP], Changsong Lin[SUP] 5 6 [/SUP], Pengping Li[SUP] 5 6 [/SUP], Qianghu Wang[SUP] 5 6 8 9 [/SUP], Shukui Wang[SUP] 10 [/SUP], Xinyi Xia[SUP] 11 12 [/SUP], Yu Liu[SUP] 13 [/SUP], Sali Lyu[SUP] 14 15 16 17 [/SUP]



Affiliations

Abstract

Type 2 diabetes (T2D) increases the risk of coronavirus disease (COVID-19). This study investigates the association between glucose control of COVID-19 patients with T2D in first 7 days after hospital admission and prognosis. A total of 252 infected inpatients with T2D in China were included. Well-controlled blood glucose was defined as stable fasting blood glucose (FBG) levels in the range of 3.9-7.8 mmol/L during first 7 days using indicators of average (FBG[SUB]A[/SUB]), maximum (FBG[SUB]M[/SUB]) or first-time (FBG[SUB]1[/SUB]) FBG levels. The primary endpoint was admission to intensive care unit or death. Hazard ratio (HR) of poorly controlled glucose level group compared with well-controlled group were 4.96 (P = 0.021) for FBG[SUB]M[/SUB] and 5.55 (P = 0.014) for FBG[SUB]A[/SUB]. Well-controlled blood glucose levels in first 7 days could improve the prognosis of COVID-19 inpatients with diabetes.

Keywords: COVID-19; Glucose control; Prognosis analysis; Type 2 diabetes.
 
Back
Top Bottom